|
CASP8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.617200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.767200E-01 |
| Normal-vs-Stage2 |
7.804100E-02 |
| Normal-vs-Stage3 |
2.773200E-01 |
| Normal-vs-Stage4 |
8.173400E-01 |
| Stage1-vs-Stage2 |
8.409300E-04 |
| Stage1-vs-Stage3 |
2.601800E-03 |
| Stage1-vs-Stage4 |
4.521200E-01 |
| Stage2-vs-Stage3 |
2.432400E-01 |
| Stage2-vs-Stage4 |
4.705900E-02 |
| Stage3-vs-Stage4 |
1.700020E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.080600E-01 |
| Normal-vs-AfricanAmerican |
6.300400E-01 |
| Normal-vs-Asian |
3.165000E-01 |
| Caucasian-vs-AfricanAmerican |
7.228600E-01 |
| Caucasian-vs-Asian |
3.169600E-01 |
| AfricanAmerican-vs-Asian |
7.556400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.948200E-01 |
| Normal-vs-Female |
8.577000E-01 |
| Male-vs-Female |
9.766200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.771400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.897800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.607200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.811000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.426400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.992040E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.106800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.518600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.909800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.315800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.996300E-02 |
| Classical-VS-Follicular |
1.07079999978055E-07 |
| Classical-VS-Other |
9.123400E-01 |
| Classical-VS-Normal |
1.784230E-01 |
| Tall-VS-Follicular |
1.962640E-01 |
| Tall-VS-Other |
4.258400E-01 |
| Tall-VS-Normal |
5.109800E-01 |
| Follicular-VS-Other |
1.352180E-01 |
| Follicular-VS-Normal |
2.354400E-02 |
| Other-VS-Normal |
7.098600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.305000E-01 |
| Normal-vs-N1 |
7.987800E-01 |
| N0-vs-N1 |
3.241600E-01 |
|
|
